Measurement of Treatment Effect in Multiple Sclerosis Clinical Trials

🔗 Access full article via JAMA Neurology

This decision analytical model study applies restricted mean survival time as a measure of treatment effect in 2 randomized clinical trials assessing disease-modifying treatments vs placebo in patients with progressive multiple sclerosis.